Category:Unassessed pharmacology articles
 | Administrators: Please do not delete this category as empty! This category may be empty occasionally or even most of the time. |
 FA |  A |  GA | B | C | Start | Stub | FL | List | Category | Disambig | Draft | File | Portal | Project | Redirect | Template | NA | ??? |
| 12 | 0 | 44 | 553 | 1,149 | 3,818 | 6,999 | 1 | 394 | 865 | 18 | 32 | 43 | 0 | 22 | 819 | 392 | 107 | 389 |
 | This page has a backlog that requires the attention of willing editors. This notice will hide when this category has fewer than 100 items. () |
Pages in category "Unassessed pharmacology articles"
The following 200 pages are in this category, out of approximately 389 total. This list may not reflect recent changes.
(previous page) (next page)A
- Talk:Acazicolcept
- Talk:Acoramidis
- Talk:Actaea racemosa
- Talk:Additive effect
- Talk:Adebrelimab
- Talk:Adiponectin receptor
- Talk:Adrenergic
- Talk:Adrenergic neuron blockers
- Talk:Alclometasone dipropionate
- Talk:Alloclamide
- Talk:Amino esters
- Talk:Aminopeptidase A inhibitor
- Talk:Aminoquinoline
- Talk:Androstenediol (disambiguation)
- Talk:Androstenedione (disambiguation)
- Talk:Androstenolone
- Talk:Anthrax vaccine
- Talk:Anthrax vaccine adsorbed
- Talk:Anti-amyloid drugs
- Talk:Anti-idiotypic vaccine
- Talk:Apoteket Hjorten
- Talk:Approvable letter
- Talk:Arven Pharmaceuticals
- Talk:Aseptic sampling
- Talk:Astegolimab
- Talk:Asunercept
- Talk:Autonomic drug
- Talk:Avicine
- Talk:AZD2693
- Talk:Aztreonam/avibactam
B
C
- Talk:C10H12FNO
- Talk:C15H24N2O2
- Talk:C20H17F3N2O4
- Talk:C20H21N3O
- Talk:Cadonilimab
- Talk:Cagrilintide
- Talk:Cagrilintide/semaglutide
- Talk:Cassava Sciences
- Talk:Catecholaminergic
- Talk:Cefaparole
- Talk:Cefoperazone/sulbactam
- Talk:Cenderitide
- Talk:Cephalosporin C
- Talk:Cerdulatinib
- Talk:Cerebroprotectant
- Talk:Chemotherapy regimen
- Talk:Chiral switch
- Talk:Chloroprednisone acetate
- Talk:Chlorphenacemide
- Talk:Cholinesterase reactivator
- Talk:Chondroprotection
- Talk:Chrysophanol
- Talk:Citrullus colocynthis
- Talk:Clavam
- Talk:Clesrovimab
- Talk:Clobetasone butyrate
- Talk:Colterol
- Talk:Comutagen
- Talk:Condoliase
- Talk:Corticosteroid-induced lipodystrophy
- Talk:COVID-19 vaccine clinical research
- Talk:Crisugabalin
- Talk:Crovalimab
- Talk:CS-27349
- Talk:CVN45502
- Talk:Cytomegalovirus vaccine
D
- Talk:Anastasios Damvergis
- Talk:DayQuil
- Talk:Dehydroepiandrosterone (disambiguation)
- Talk:Deuruxolitinib
- Talk:Peter B. Dews
- Talk:Dextrin
- Talk:Diclofenac etalhyaluronate
- Talk:Direct-acting antivirals
- Talk:Directive 65/65/EEC
- Talk:Dirlotapide
- Talk:Discovery and development of beta2 agonists
- Talk:Discovery and development of bisphosphonates
- Talk:Discovery and development of cephalosporins
- Talk:Discovery and development of tubulin inhibitors
- Talk:Dissolvable tobacco
- Talk:Disulfiram-like drug
- Talk:Dokumeds
- Talk:Dragonite International
- Talk:Dronabinol/acetazolamide
- Talk:Drug repositioning
- Talk:DTaP-Hib vaccine
- Talk:Dual amylin and calcitonin receptor agonists
E
- Talk:Eberconazole
- Talk:Ecnoglutide
- Talk:Effective half-life
- Talk:Efocipegtrutide
- Talk:Efpeglenatide
- Talk:Elezanumab
- Talk:Emixustat
- Talk:Entospletinib
- Talk:Envafolimab
- Talk:Ephedrine/ethylmorphine
- Talk:Epiestriol (set index)
- Talk:Epstein–Barr virus vaccine
- Talk:Erfonrilimab
- Talk:Erythromycin/sulfafurazole
- Talk:Estradiol tetrahydropyranyl ether
- Talk:Ethics in pharmaceutical sales
- Talk:Etiocholanediol
- Talk:EudraLex
- Talk:Eye drop
F
G
- Talk:G1 Therapeutics
- Talk:GABA receptor antagonist
- Talk:Gasotransmitter
- Talk:GLP1 poly-agonist peptides
- Talk:Glucagon receptor agonist
- Talk:Glucarpidase
- Talk:Glycine receptor agonist
- Talk:Glycine receptor antagonist
- Talk:Good automated manufacturing practice
- Talk:Gosogliptin
- Talk:Government Pharmaceutical Organization
- Talk:GPC Biotech
- Talk:GSK2831781
- Talk:Gutka
H
- Talk:Haryana Raxil drug purchase case
- Talk:Healthy Skepticism
- Talk:Noël-Étienne Henry
- Talk:Hepatitis A and typhoid vaccine
- Talk:Hepatitis C vaccine
- Talk:Hershel L. Herzog
- Talk:Robert Charles Hider
- Talk:Takeru Higuchi
- Talk:Hill equation (biochemistry)
- Talk:History of entheogenic drugs
- Talk:HIV vaccine development
- Talk:HL156A
- Talk:Hookworm vaccine
- Talk:Hycomine
- Talk:Hydrocortisone cypionate
- Talk:Hydrocortisone phosphate
- Talk:Hydrocortisone sodium succinate
- Talk:Hydrocortisone valerate
- Talk:Hydroxyestrone
- Talk:Hydroxypregnanedione
- Talk:Hydroxypregnenolone
I
- Talk:Inavolisib
- Talk:Initial volume of distribution
- Talk:Inovio COVID-19 vaccine
- Talk:Insulin efsitora alfa
- Talk:Insulin icodec/semaglutide
- Talk:International Pharmaceutical Excipients Council
- Talk:International Society for the History of Pharmacy
- Talk:Intrathecal administration
- Talk:Ionis Pharmaceuticals
J
L
- Talk:Lanabecestat
- Talk:Lascufloxacin
- Talk:John S. Lazo
- Talk:Donald E. Letendre
- Talk:Levilimab
- Talk:Stanislas Limousin
- Talk:List of largest pharmaceutical settlements
- Talk:List of off-label promotion pharmaceutical settlements
- Talk:List of psychotropic medications
- Talk:Lists of investigational drugs
- Talk:Litifilimab
- Talk:Martin J. Lohse